Literature DB >> 19850830

Retinal basement membrane abnormalities and the retinopathy of Alport syndrome.

Judy Savige1, John Liu, Delia Cabrera DeBuc, James T Handa, Gregory S Hageman, Yan Yan Wang, John D Parkin, Brendan Vote, Rob Fassett, Shirley Sarks, Deb Colville.   

Abstract

PURPOSE: To determine the effects of X-linked and autosomal recessive Alport syndrome on retinal basement membranes and how these result in the characteristic perimacular dot-and-fleck retinopathy, lozenge, and macular hole.
METHODS: The type IV collagen chains present in the normal retina were determined immunohistochemically. Ten patients with Alport syndrome underwent retinal photography and optical coherence tomography to determine the thickness of the internal limiting membrane (ILM) by segmentation analysis, the layers affected by the retinopathy, and any correlates of the lozenge and macular hole. Bruch's membrane was examined directly by electron microscopy in a donated Alport eye.
RESULTS: The alpha3alpha4alpha5 type IV collagen network was present in the normal ILM and in the retinal pigment epithelium basement membrane of Bruch's membrane. In Alport syndrome, the ILM/nerve fiber layer and Bruch's membrane were both thinned. The dot-and-fleck retinopathy corresponded to hyperreflectivity of the ILM/nerve fiber layer in the distribution of the nerve fiber layer. The lozenge and macular hole corresponded to temporal macular thinning. The thinning across the whole retina was principally due to thinning of the ILM/nerve fiber layer and inner nuclear layer.
CONCLUSIONS: The Alport dot-and-fleck retinopathy results primarily from abnormalities in the ILM/nerve fiber layer rather than in Bruch's membrane. Thinning of the ILM/nerve fiber layer contributes to the retinopathy, lozenge, and macular hole, possibly through interfering with nutrition of the overlying retina or clearance of metabolic by-products.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850830      PMCID: PMC2868425          DOI: 10.1167/iovs.08-3323

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration.

Authors:  S R Russell; R F Mullins; B L Schneider; G S Hageman
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

2.  Tapetal-like sheen associated with fleck retinopathy in Alport syndrome.

Authors:  Guadalupe Cervantes-Coste; Graciana Fuentes-Paez; Itamar Yeshurun; J Manuel Jimenez-Sierra
Journal:  Retina       Date:  2003-04       Impact factor: 4.256

3.  Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).

Authors:  Velidi H Rao; George E Lees; Clifford E Kashtan; Ryochi Nemori; Rakesh K Singh; Daniel T Meehan; Kathyrn Rodgers; Brian R Berridge; Gautam Bhattacharya; Dominic Cosgrove
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Macular lesions in Alport's disease.

Authors:  B C Polak; B L Hogewind
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

5.  The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.

Authors:  Ke Wei Zhang; Deb Colville; Rachel Tan; Colin Jones; Stephen I Alexander; Jeffrey Fletcher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

6.  Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.

Authors:  K Yoshioka; S Hino; T Takemura; S Maki; J Wieslander; Y Takekoshi; H Makino; M Kagawa; Y Sado; C E Kashtan
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes?

Authors:  J A Govan
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

8.  Clinical features and pathogenesis of Alport retinopathy.

Authors:  K M Gehrs; S C Pollock; G Zilkha
Journal:  Retina       Date:  1995       Impact factor: 4.256

9.  Alport's syndrome with bilateral macular hole.

Authors:  U O Mete; C Karaaslan; M K Ozbilgin; S Polat; O Tap; M Kaya
Journal:  Acta Ophthalmol Scand       Date:  1996-02

10.  [Considerations on the pathogenesis of the cochleo-renal syndrome (author's transl)].

Authors:  W Arnold
Journal:  Acta Otolaryngol       Date:  1980 Mar-Apr       Impact factor: 1.494

View more
  24 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

Review 2.  Tissue linkage through adjoining basement membranes: The long and the short term of it.

Authors:  Daniel P Keeley; David R Sherwood
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

3.  The Peculiar Pattern of Type IV Collagen Deposition in Epiretinal Membranes.

Authors:  Marì Regoli; Gian Marco Tosi; Giovanni Neri; Annalisa Altera; Daniela Orazioli; Eugenio Bertelli
Journal:  J Histochem Cytochem       Date:  2019-12-20       Impact factor: 2.479

Review 4.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

5.  Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5.

Authors:  Rajeev Deva; Mohamad Afzal Alias; Deb Colville; Foong Kien Newk-Fon Hey Tow; Qi Lun Ooi; Sky Chew; Nor Mohamad; Anastasia Hutchinson; Ignatios Koukouras; David A Power; Judith Savige
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

6.  Temporal macular thinning associated with X-linked Alport syndrome.

Authors:  Faisal Ahmed; Kandon K Kamae; Denise J Jones; Margaret M Deangelis; Gregory S Hageman; Martin C Gregory; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

7.  Missing Internal Limiting Membrane during Macular Hole Repair in Alport Syndrome.

Authors:  Sarah G Chaudhry; Gerald Liew; Adrian T Fung
Journal:  Case Rep Ophthalmol       Date:  2021-05-03

Review 8.  Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2020-09-18       Impact factor: 21.198

9.  A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities.

Authors:  Chan Zhao; Fang Wang; Yanqin Zhang; Yubing Wen; Ying Su; Chengfen Zhang; Ruifang Sui; Fei Xu; Jie Ding; Fangtian Dong
Journal:  Mol Vis       Date:  2012-08-08       Impact factor: 2.367

10.  Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis.

Authors:  Xiao-Dan Yao; Xin Chen; Gao-Yuan Huang; Yan-Ting Yu; Shu-Tian Xu; Yang-Lin Hu; Qing-Wen Wang; Hui-Ping Chen; Cai-Hong Zeng; Da-Xi Ji; Wei-Xin Hu; Zheng Tang; Zhi-Hong Liu
Journal:  Orphanet J Rare Dis       Date:  2012-12-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.